ArticleFrontiers in oncology2025

Treatment of metastatic ALK-positive non-small cell lung cancer: indirect comparison of different ALK inhibitors using reconstructed patient data.

Vera Damuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.